BioCentury
ARTICLE | Company News

Bausch & Lomb, Pfizer sales and marketing update

March 9, 2009 7:00 AM UTC

Under a five-year deal, the partners will co-promote each other's ophthalmic drugs in the U.S. The deal includes Pfizer's Xalatan latanoprost and Bausch & Lomb's Alrex and Lotemax loteprednol etab...